Basal autophagy is pivotal for Hodgkin and Reed-Sternberg cells' survival and growth revealing a new strategy for Hodgkin lymphoma treatment

As current classical Hodgkin lymphoma (cHL) treatment strategies have pronounced side-effects, specific inhibition of signaling pathways may offer novel strategies in cHL therapy. Basal autophagy, a regulated catabolic pathway to degrade cell's own components, is in cancer linked with both, tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Birkenmeier, Katrin, Moll, Katharina, Newrzela, Sebastian, Hartmann, Sylvia, Dröse, Stefan, Hansmann, Martin-Leo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216819/
https://www.ncbi.nlm.nih.gov/pubmed/27366944
http://dx.doi.org/10.18632/oncotarget.10300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216819/
https://www.ncbi.nlm.nih.gov/pubmed/27366944
http://dx.doi.org/10.18632/oncotarget.10300

Ejemplares similares